Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)

Trial Profile

Ubenimex in Adult Patients With Lymphedema of The Lower Limb: a Phase 2, RAndomized, Double-blind, Placebo-controlled Study of Efficacy, Safety, and Pharmacokinetics (ULTRA)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs Ubenimex (Primary)
  • Indications Lymphoedema
  • Focus Therapeutic Use
  • Acronyms ULTRA
  • Sponsors Eiger BioPharmaceuticals
  • Most Recent Events

    • 12 May 2017 According to an Eiger BioPharmaceuticals media release, the company anticipates to complete enrolment in Q4 2017.
    • 23 Mar 2017 According to Eiger BioPharmaceuticals media release, the company anticipates to complete enrolment in Q3 2017 and data in Q2 2018.
    • 10 Aug 2016 According to Eiger BioPharmaceuticals media release, the company anticipates data from this trial in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top